Adaptive Design in Drug Development
Author Information
Author(s): Brahmachari Ballari Bhatt Arun
Primary Institution: Clininvent Research Pvt. Ltd.
Hypothesis
Can adaptive trial designs improve the efficiency and success of clinical drug development?
Conclusion
Adaptive designs can enhance trial efficiency and success rates but come with complexities and regulatory scrutiny.
Supporting Evidence
- Adaptive designs allow for real-time modifications to ongoing trials based on accumulating data.
- These designs can lead to more efficient studies with fewer subjects and shorter durations.
- Regulatory agencies are cautious about adaptive designs due to potential misuse and complexity.
Takeaway
Adaptive designs are like changing the rules of a game while you're playing to make it better. They help researchers find out if a medicine works faster and with fewer people.
Methodology
The article discusses the concept and implementation of adaptive trial designs in clinical research.
Potential Biases
There is a risk of operational bias if interim results influence trial conduct.
Limitations
Adaptive trials can be complex to design and may introduce operational bias if not properly managed.
Want to read the original?
Access the complete publication on the publisher's website